Login / Signup

Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: A review.

Ramkumar SamynathanThiruvengadam MuthuShivraj Hariram NileMohammad Ali ShariatiMaksim B RebezovRaghvendra Kumar MishraSathishkumar RamalingamSureshkumar PeriyasamyIll-Min ChungMirian PateiroJosé Manuel Lorenzo Rodriguez
Published in: Critical reviews in food science and nutrition (2021)
Tea manufactured from the cultivated shoots of Camellia sinensis (L.) O. Kuntze is the most commonly consumed nonalcoholic drink around the world. Tea is an agro-based, environmentally sustainable, labor-intensive, job-generating, and export-oriented industry in many countries. Tea includes phenolic compounds, flavonoids, alkaloids, vitamins, enzymes, crude fibers, protein, lipids, and carbohydrates, among other biochemical constituents. This review described the nature of tea metabolites, their biosynthesis and accumulation with response to various factors. The therapeutic application of various metabolites of tea against microbial diseases, cancer, neurological, and other metabolic disorders was also discussed in detail. The seasonal variation, cultivation practices and genetic variability influence tea metabolite synthesis. Tea biochemical constituents, especially polyphenols and its integral part catechin metabolites, are broadly focused on potential applicability for their action against various diseases. In addition to this, tea also contains bioactive flavonoids that possess health-beneficial effects. The catechin fractions, epigallocatechin 3-gallate and epicatechin 3-gallate, are the main components of tea that has strong antioxidant and medicinal properties. The synergistic function of natural tea metabolites with synthetic drugs provides effective protection against various diseases. Furthermore, the application of nanotechnologies enhanced bioavailability, enhancing the therapeutic potential of natural metabolites against numerous diseases and pathogens.
Keyphrases
  • ms ms
  • healthcare
  • public health
  • primary care
  • cancer therapy
  • drug delivery
  • blood brain barrier
  • genome wide
  • photodynamic therapy
  • binding protein
  • depressive symptoms
  • multidrug resistant